ProfessorJames Sharman

Professorial Research Fellow

Menzies Institute for Medical Research

  • Professorial Research Fellow
    Menzies Institute for Medical Research
  • +61 3 6226 4709 (Work)
  • Menzies Institute for Medical Research, Menzies Institute for Medical Research, Medical Science Precinct, Hobart CBD Campuses, TAS

FUNDED PROJECTS

  • GRANT
    Implementing improved blood pressure measurement in general practice
    1 Sep 2026 - 30 Sep 2030
    People funded by this grant:
    • Sharman J,
    • Schutte A,
    • Nelson M,
    • Gall S,
    • Schlaich M
    Project Total: $1,128,106; High blood pressure (BP) is the single largest modifiable risk factor accounting for the greatest burden of death and disability from cardiovascular disease (CVD) in Australia. Accurate BP measurement is essential so that correct hypertension diagnosis and clinical care can be provided to lower risk for future CVD events (i.e. strokes, heart attacks). Most hypertension is managed in general practice, but it is not feasible for general practitioners (GPs) to perform standardised and accurate BP measurement in this setting, mainly due to time contraints. The result is that GPs do not trust the BP values and this leads to therapeutic inertia and increases in avoidable strokes and heart attacks. This project addresses this problem by implementing an intervention to accurately measure BP by using automated office BP (AOBP) in a process that has been co-designed with GPs, other health care professionals and community. AOBP is a standardised, automated procedure that is undertaken by a trained person in a quiet area outside of the GP examination room prior to consultation. This method is already recommended by guidelines and desired by GPs but not currently used because of barriers faced by GPs, including lack of access to equipment, education and training to measure and interpret AOBP. All these resources will be provided in this project in which AOBP intervention will be implemented in general practice clinics across Australia. It is expected that the AOBP intervention will be associated with significantly increased proportion of patients with treated and controlled hypertension. The project will also determine the essential elements for sustainable adoption of AOBP in general practice according to established implementation science frameworks. Ultimately, the project will provide a high-quality system of care resulting in improved BP measurement, better BP control, lower risk for adverse CVD events, and major health cost savings in Australia. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($2,256,211); University of Tasmania.
  • GRANT
    Addressing the health needs of Tasmania: The Tasmanian Collaboration for Health Improvement (TCHI)
    1 May 2025 - 30 Apr 2027
    People funded by this grant:
    • Aitken D,
    • Arya D,
    • Powell S,
    • Sharman J,
    • Winzenberg T
    Project Total: $1,000,000; Tasmania has the oldest, most rapidly ageing population in Australia and some of the poorest health outcomes of any Australian state or territory due to higher levels of socioeconomic disadvantage, chronic disease and disability. It faces regional health challenges with a highly geographically dispersed population. To address these health needs, the Tasmanian Collaboration for Health Improvement (TCHI) was formally established in 2018. TCHI is a collaborative partnership between the Tasmanian Department of Health and Tasmanian Health Services, the University of Tasmania, Primary Health Tasmania (Tasmanias sole Primary Health Network) and Health Consumers Tasmania. This is a strong, committed partnership evidenced by the major investment from its partners since its inception. It has an established governance and leadership structure. With one health system, one Primary Health Network and one University working together, the collaboration is in a unique position to rapidly and effectively translate research evidence into practice and policy and improve the health outcomes for Tasmanians. TCHI has co-developed a series of five priority projects that will address specific health needs in Tasmania. Project 1 will implement and evaluate a co-designed intervention in general practice to reduce unwarranted surgical referral for osteoarthritis. Project 2 will implement a nation-leading model for monitoring and managing blood pressure in primary care to reduce the burden of hypertension in the State. Project 3 focuses on improving services, health outcomes and preventing hospitalisations for individuals that are frequently admitted to hospital. Project 4 aims to reduce the pressure on emergency departments through the implementation of a novel Emergency Department Learning Health System that has been co-developed with all TCHI partners. Project 5 will co-design approaches for measuring and monitoring racism experienced by First Peoples in Tasmanias public health system. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Collaborations in Health Services Research ($2,000,000); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    NW Hypertension AoBP Pilot project
    1 Feb 2025 - 31 Dec 2027
    People funded by this grant:
    • Sharman J,
    • Coe S,
    • Nelson M,
    • Cleland V,
    • Jose K
    Project Total: $0; Pilot project of Automated Blood Pressure monitoring in General Practice. The AOBP Pilot study will be conducted at five (5) Tasmanian primary care clinics. Each pilot site will endeavour to recruit a minimum of two (2) patients per day (10 patients per week) for the AOBP measurements for the duration of the pilot study. Pilot sites will also request returning patients with follow-up appointments during the six-month AOBP measurement period have repeat AOBP measurements. The evaluation of the pilot study will be conducted by UTAS together with the Collaborator and guided by the Medical Research Council UKs framework designed for conducting process evaluations of complex public health interventions.[i] The approach that will be used to assess the implementation strategy, feasibility and acceptability of the AOBP protocol will include analysis of self-reported patient clinical data, and qualitative and quantitative data from interviews and surveys with all end-users of AOBP (GPs, practice staff, patients). Contextual factors relevant to the implementation of AOBP will also be evaluated.[ii] Funded by: Office of Health (Internal Contribution); University of Tasmania.
  • GRANT
    Statins to reduce adverse cardiovascular effects from exposure to bushfire smoke
    1 Jan 2025 - 31 Dec 2028
    People funded by this grant:
    • Huynh Q,
    • Johnston F,
    • Marwick T,
    • Sharman J,
    • Carlsten C
    Project Total: $999,020; As severe bushfires increase around the world, more people are being exposed to longer and more extreme episodes of air pollution, which is the leading global environmental risk factor for cardiovascular diseases (CVD), such as heart attacks and stroke. Our research has two main goals: (1) to study how short-term (hours) and long-term (years) exposure to bushfire smoke affects early signs of cardiovascular disease, and (2) to test if statin medications reduce these negative effects over both the short and long term. Statin medications are commonly used to treat high blood cholesterol but have other useful actions such as anti-inflammatory effects. In theory, they have a lot of promise for protecting against many of the known harmful actions of air pollution on the cardiovascular system, but this has not been tested in practice. We will use existing data on air pollution and information from current studies and clinical trials to compare the effectiveness of statins compared with a placebo in the development and progression of CVD among people at low to medium risk. In Study 1 led by the Baker Institute, we will examine how long-term, exposure to general air pollution and bushfire smoke affects the buildup of plaque in the arteries. We will use cardiac CT scans to measure this plaque buildup and see if people taking statins had reduced impacts. We will also investigate whether the protective effects of statins varies among people with different levels of CVD risk. This will help plan the best individually tailored treatment strategies. In Study 2, led by Menzies, we will examine how short-term, exposure to bushfire smoke subtly affects heart, blood vessel and immune responses and find out if people using statins are protected against some of these effects. We will invite 50 participants from an existing long term study comparing statin treatment with a placebo, to join a trail involving controlled exposure to bushfire smoke for 2 hours and, at a separate time, to fresh filtered air for 2 hours. To avoids bias in the research, participants will not know if they are using a real statin or a placebo, and will not know the order of their exposure to the smoke or filtered air. The amount of smoke will set to levels commonly experienced in the community during burn-offs or on colder evenings in areas affected by wood-heater smoke. We are focusing on early, sub-clinical, signs of cardiovascular disease to: (1) safely study immediate changes and underlying mechanisms to learn more about how air pollution contributes to cardiovascular disease, and (2) to find potential problems and solutions at early stages of development of disease, well before air pollution leads to serious complications, such as a heart attack. The results of this research will guide treatments to lower overall risk and contribute to new strategies for protecting cardiovascular health during extreme smoke events. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Targeted Call for Research; Baker Heart and Diabetes Institute; Griffith University; La Trobe University; University of British Columbia; University of Sydney; Patient Experience Agency Ptd Ltd; University of Tasmania.
  • GRANT
    Implementing novel approaches to transform blood pressure control
    1 Jul 2023 - 30 Jun 2025
    People funded by this grant:
    • Schutte A,
    • Neal B,
    • Schlaich M,
    • Chow C,
    • Peiris D
    Project Total: $0; Harnessing NSW leadership to drive a multifaceted approach in translation research to increase blood pressure control rates from 32% to 70% by 2030. Funded by: NSW Department of Health - Grant; University of New South Wales; University of Tasmania.
  • GRANT
    Saving lives with better blood pressure management
    1 Jan 2023 - 31 Dec 2027
    People funded by this grant:
    • Sharman J,
    • Picone D
    Project Total: $655,150; Cuff measured blood pressure (BP) is one of the most important tests in all clinical medicine. However, cuff BP is not accurate in many individuals, and this can increase the likelihood of avoidable cardiovascular events (heart attack, stroke, kidney failure) through incorrect diagnosis and inappropriate medical care. My research to date has identified problems with the accuracy of standard cuff BP devices used every day in clinical practice. Problems with accuracy are more apparent in older people and those with greater arterial stiffness. My clinical BP physiology work has also identified potential solutions to help achieve better, more accurate cuff BP measurements. Informed by my previous work, the proposed research program will include a series of studies using various data sources to achieve my vision of better BP measurement to minimise the burden of preventable cardiovascular disease, including: 1. BP TYPE study will develop, validate and assess the clinical effectiveness of a method for accurate measurement of cuff BP using machine learning analysis of BP wave shapes. 2. INSPECT consortium studies will examine BP measurement differences between cuff BP and invasive BP and factors that influence the accurate measurement of BP. 3. TAVI-BP study will generate foundational knowledge on the accuracy of cuff BP and BP wave shapes in patients with aortic stenosis who are undergoing trans-aortic valve implantation. 4. AIM-BP collaborative. I am co-lead of this international group and we will perform translationally focused research that aims to promote the use of best practice BP measurement methods and devices that are currently available. This program of research will comprehensively address the problem of inaccurate BP measurement and contribute to better blood pressure measurement that will minimise the burden of preventable cardiovascular disease in Australia and globally. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Fellowship-Investigator Grant; University of Sydney; University of Tasmania.
  • GRANT
    IMplementing clinical Pathways for Acute Care in Tasmania (IMPACT)
    1 Apr 2022 - 31 Mar 2028
    People funded by this grant:
    • Tran V,
    • Prior S,
    • Neil A,
    • Sharman J,
    • Radford J
    Project Total: $2,919,109; Clinical pathways (CPs) are multidisciplinary tools enabling large-scale consistent practice of evidence-based medicine, and have the potential to improve patient care and reduce pressure on Emergency Departments. The effectiveness of CPs in Australia is not well known. IMPACT will utilise a consumer-driven approach to investigate barriers for CP use, develop a scalable and sustainable implementation strategy for CPs, and identify CP priorities to drive further excellence in health care. Funded by: Medical Research Future Fund - Grant-2022 Models of Care to Improve the Efficienc ($2,919,109); University of Tasmania ($108,157).
  • GRANT
    Assessing the clinical value of exercise stress echocardiography: an EXERcise stress Test collaboratION (EXERTION) study
    1 Jan 2022 - 31 Dec 2022
    People funded by this grant:
    • Schultz M,
    • Sharman J,
    • Roberts-Thomson P,
    • Marwick T,
    • Otahal P
    Project Total: $24,951; The primary objective of this study is to determine the clinical value of ESE in the prediction of CAD compared to an exercise stress ECG test. Specifically, we aim to determine the association of ESE test result with 1) probability of subsequent coronary angiogram procedure, and 2) the risk of CAD (as confirmed by coronary angiography) in comparison to that of an age- and sex-matched group of participants who completed a simple exercise stress ECG test. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,951); University of Tasmania.
  • GRANT
    Implementation and evaluation of the Rapid Access Chest Pain Clinic (RACPC) a process evaluation.
    1 Jan 2022 - 1 Sep 2023
    People funded by this grant:
    • Chapman N,
    • Black A,
    • Sharman J,
    • Gavaghan D
    Project Total: $24,996; The Rapid Access Chest Pain Clinic (RACPC) is a patient-centred model of care that is a more efficient model of care and has reduced patient's risk of cardiovascular disease. This project will conduct a detailed evaluation of the clinic to identify opportunities for improvement and for implementation in other settings. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,996); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Risk-guided Disease managEment plan to prevEnt heart failure in patients treated with previous cheMotherapy (REDEEM)
    1 Jan 2022 - 31 Dec 2025
    People funded by this grant:
    • Marwick T,
    • Sharman J,
    • Whitmore K,
    • Schultz M
    Project Total: $339,163; The study aims to identify cardiac complications of cancer treatment (chemotherapy) and find exercise and medical treatment that will improve these complications. Some cancer treatments lead to a risk of heart muscle damage. If this process is left unchecked, it can sometimes cause heart failure, especially as patients grow older and develop other risks for heart failure. In this project an ultrasound of the heart (echocardiogram) will be taken in order to measure cardiac status. We are trying to establish whether information from simple tests of the heart could guide treatment to protect patients from developing heart failure. Funded by: Baker Heart and Diabetes Institute ($339,163); University of Tasmania.
  • GRANT
    Transforming blood pressure control in primary care using the next generation of blood pressure measurement devices: The NEXTGEN-BP study
    1 Jan 2022 - 31 Dec 2026
    People funded by this grant:
    • Schutte A,
    • Patel A,
    • Chow C,
    • Gnanenthiran S,
    • Webster R
    Project Total: $1,936,263; Uncontrolled high blood pressure (BP) is the leading cause of death in Australia. However, only 32% of Australians with hypertension have their BP controlled. Treatment inertia is largely driven by uncertainty around usual? BP levels for both the general practitioner (GP) and the patient resulting in reluctance by both parties to initiate or intensify treatment. This is due to inadequate assessment and interpretation of blood pressure. A recent innovation holds promise for a simple patient-friendly solution that will simultaneously solve both the above issues for radically more effective BP control. A wrist-worn sensor-based cuffless BP wearable device, namely the Aktiia (Switzerland) device now simplifies self-monitoring of BP. The validated Aktiia device6 provides accurate automated 24/7 BP measures hourly for weeks at a time, with no user intervention or disturbance. Based on hundreds of readings, the device reports the percentage of BP readings that are in the normal range on a mobile phone app. Instead of using clinic BP to guide treatment decisions, GPs and patients will have access to the percentage of BP at target over a past month (hundreds of BPs taken 24/7) and engage in a shared decision-making model to navigate treatment titration. GPs will be provided a titration strategy based on the % BP at goal. Funded by: Medical Research Future Fund - Grant-Primary Health Care Research; National Health & Medical Research Council; National Health & Medical Research Council; University of New South Wales; The George Institute for Global Health; University of Tasmania.
  • GRANT
    Accurate blood pressure with machine learning
    1 Jan 2021 - 31 Dec 2024
    People funded by this grant:
    • Picone D,
    • Sharman J,
    • Alavi A,
    • Schultz M,
    • Black A
    Project Total: $446,000; Cuff measured blood pressure is one of the most important tests in all clinical medicine. However, cuff BP is not accurate in many people, and this can lead to incorrect diagnosis and inappropriate medical care. This research program seeks to develop and validate a new and more accurate way to measure cuff BP using machine learning technology. Funded by: Royal Hobart Hospital Research Foundation - Grant-Major Project ($446,000); University of Tasmania ($27,350).
  • GRANT
    Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring (EDCAD-PMS)
    1 Jan 2021 - 31 Dec 2023
    People funded by this grant:
    • Marwick T,
    • Whitmore K,
    • Sharman J
    Project Total: $149,300; The research will assess whether genetic (polygenic?) risk scores can improve patient selection for more advanced screening tests, such as coronary imaging or angiograms?, and risk factor management such as elevated cholesterol Main aims for this study are to identify whether: * Polygenetic risk score (PRS) and metabolic risk score can predict the presence of coronary calcium * Knowledge of the PRS result is better or worse than knowledge of the CT scan result in guiding people to reduce their risk (by changing lifestyle and taking medications) Funded by: Baker Heart and Diabetes Institute - Clinical Trial ($149,300); University of Tasmania.
  • GRANT
    Improved cardiovascular disease health service delivery in Australian (IDEAL study)
    1 Feb 2020 - 31 Dec 2024
    People funded by this grant:
    • Sharman J,
    • Nelson M,
    • Venn A
    Project Total: $1,071,230; Cardiovascular disease (CVD) has the highest burden of global disease and highest level of health care expenditure in Australia. Most of the management of CVD is performed in general practice, where the recommended strategy is to determine absolute CVD risk based on multiple factors (e.g. cholesterol, blood pressure, diabetes, smoking). Australian primary care doctors are not yet adopting guideline recommendations, with as few as 30% using risk calculators, and this leads to people remaining at high risk for otherwise avoidable CVD events. All partners in this grant are working together to rectify this evidence-practice gap, using a new, yet simple and widely implementable, digital health service that has been developed by researchers, industry, health service providers and policy makers. The concept involves absolute CVD risk being measured at pathology services in patients referred for blood lipid assessment. Patients have blood pressure measured and CVD risk factors collated electronically by pathology services using an automated, high throughput approach, with absolute CVD risk results conveyed to general practitioners via an established pathology reporting system. Abnormal results are highlighted and advice provided regarding appropriate, guideline-directed action. Significant development work that confirms proof-of-concept has been completed. This program will refine and test the clinical value of the new health service method upon establishment statewide across Tasmanian pathology services. In an Australian first, the system is designed for research infusion, with all information data-based (through UTAS) and serving as a platform for rapid assessment of clinical value by linkage to health outcomes. Ultimately, the new service is expected to improve CVD outcomes, reduce health care costs and improve doctor and patient experiences. Importantly, the model is transferable to other national and international settings. Funded by: National Health & Medical Research CouncilNational Health & Medical Research Council - Grant-Partnership Project ($2,006,460); Uscom Ltd ($68,000); University of Tasmania.
  • GRANT
    Risk-guided strategy for reducing readmission for Acute Decompensated Heart Failure (RiskHELP)
    1 Nov 2019 - 30 Jun 2022
    People funded by this grant:
    • Marwick T,
    • Sharman J,
    • Whitmore K,
    • Dwyer N,
    • Izzettin O
    Project Total: $107,400; A prospective RCT with 320 HF randomised patients admitted with Acute Decompensated Heart Failure (ADHF) confirmed by diagnosis from RHH. Eligible patients (based on study inclusion exclusion criteria), identified by applying the TAS-Help (Study based at Menzies) algorithm as being at high risk for hospital readmission and/or death, will be randomised into two groups of 160 patients each arm. The control arm will receive usual care while the intervention arm will receive DMP-Plus. Patients with ADHF will be screened for a period of 24 months or until targeted sample size is met. Funded by: Medical Research Future Fund - Grant - Keeping Australians Out of Hospital; Baker Heart and Diabetes Institute; University of Tasmania.
  • GRANT
    A smarter way to measure blood pressure
    1 Jan 2019 - 31 Dec 2021
    People funded by this grant:
    • Picone D,
    • Sharman J,
    • Schultz M,
    • Black A,
    • Roberts-Thomson P
    Project Total: $23,189; Standard cuff blood pressure (BP) measurements have highly variable accuracy. We recently discovered new BP categories that are associated with different risk related to BP. This project aims use information from the BP categories to develop and validate a 'smart' cuff BP method that measures BP more accurately. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($23,189); University of Tasmania.
  • GRANT
    Prevalence and cardiovascular risk associated with exaggerated exercise blood pressure among people with type 2 diabetes
    1 Jan 2019 - 30 Jun 2020
    People funded by this grant:
    • Sharman J,
    • Schultz M,
    • La Gerche A
    Project Total: $59,958; People with type 2 diabetes are at higher risk of death and disability from cardiovascular disease such as heart attack and stroke, for which the main contributing factor is high blood pressure. Since high blood pressure can be treated to lower the risk of cardiovascular disease, it is important that people with type 2 diabetes have their blood pressure correctly diagnosed. Pilot data from the investigator team have shown that people with type 2 diabetes have much greater propensity to have an exaggerated (high) blood pressure response to exercise, and this is a cardinal sign of abnormal (high) blood pressure that is missed using standard measurements under resting conditions. This has major implications for the potential of exercise stress test data as a means to identify people at high risk otherwise overlooked. These pilot observations will be confirmed in this current proposal using a nationally representative dataset of 125,000 people, with linkage to cardiovascular hospitalisations and death, in the largest analysis of its kind. Information from this study will inform clinical exercise stress test guidelines to improve care and reduce cardiovascular events among people with type 2 diabetes. Funded by: Diabetes Australia Research Program - Grant ($59,958); University of Tasmania.
  • GRANT
    The Royal Hobart Hospital's innovative Rapid Access Chest Pain Clinic (RACPC): A health economic evaluation of patient, RHH and community benefits
    1 Jan 2019 - 31 May 2020
    People funded by this grant:
    • Campbell J,
    • Black A,
    • Palmer A,
    • Sharman J,
    • Hensher M
    Project Total: $24,952; The overall aim of this project is to conduct a comprehensive health economic evaluation of the RHH's cutting-edge Rapid Access Chest Pain Clinic (RACPC) patient care model, compared to the usual care General Cardiology (GCC) clinic model for RHH patients with newly presented chest pain. The RACPC commenced in June 2014 and has realised positive clinical outcomes for its patients. Our comprehensive health economic investigation will build on the clinical work to systematically evaluate the health economic benefits of this innovative model's patient pathways for people who present to the RHH's Emergency Department (approximately 70%) or by referral from a primary care physician (approximately 30%) with new onset chest pain. Funded by: Royal Hobart Hospital Research Foundation - Grant-Project ($24,952); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    ERA 2018/2019 REC Member: Professor James Sharman
    1 Jan 2018 - 31 Mar 2019
    People funded by this grant:
    • Sharman J
    Project Total: $18,851; Funded by: Australian Research Council ($18,851); University of Tasmania.
  • CONSULTANCY/CONTRACT RESEARCH
    Project title: Comparison of Cardiovascular Disease Prevention Guidelines between UK, US and Australia.
    1 Apr 2017 - 1 Apr 2019
    People funded by this grant:
    • Sharman J,
    • McManus R,
    • Breslin M
    Project Total: $550; We will apply absolute CVD guidelines to national public health survey data for each country to assess proportional differences in people receiving treatment based on country guideline and population. Funded by: University of Oxford ($550); University of Tasmania.
  • GRANT
    Clinical importance of neural baroreflex sensitivity in the Paris Prospective Study 3
    1 May 2016 - 1 May 2017
    People funded by this grant:
    • Sharman J
    Project Total: $7,500; Appropriate regulation of blood pressure via baroreflex alterations to heart rate and peripheral arteries is critical for cardiovascular health, yet little is known about the neural components controlling the baroreflex (neural baroreflex sensitivity) and its relation to blood pressure. The Paris Prospective Study 3 is an INSERM supported study among 10,000 French subjects, initiated to identify novel heart rate and carotid artery stiffness predictors of sudden death from cardiovascular disease. All subjects have had extensive testing, including continuously recorded echotracking of the carotid artery, neural baroreflex sensitivity, central and brachial blood pressure. All subjects have also undergone exercise stress testing and there is a 10 year follow up period currently underway. A series of cross sectional analyses will be undertaken to address several novel scientific questions related to neural baroreceptor sensitivity and blood pressure under resting and exercise conditions. Principal research questions are to determine: 1. The independent relationship between neural baroreceptor sensitivity and central blood pressure (systolic and central pulse pressure) 2. The relationship of the neural baroreceptor sensitivity -central blood pressure interaction with blood pressure variability. 3. The influence of neural baroreceptor sensitivity on abnormal blood pressure responses to exercise. Funded by: High Blood Pressure Research Council of Australia - Franco-Australian Exchange ($7,500); University of Tasmania.
  • GRANT
    Improved cardiovascular Disease hEALth service delivery in Australia (the IDEAL study)
    1 May 2016 - 1 May 2019
    People funded by this grant:
    • Sharman J,
    • Schultz M,
    • Marwick T,
    • Thomson P
    Project Total: $429,678; This program will establish and test the clinical value of a health service method to deliver patient information on cardiovascular disease (CVD) risk to general practitioners. This new method to measure and report absolute CVD risk will be developed within Tasmanian Pathology Services and tested by clinical-trial with linkage to CVD outcomes. Funded by: Royal Hobart Hospital Research Foundation - Grant - Project Grant Funding ($429,678); University of Tasmania.
  • GRANT
    Improved clinical assessment of blood pressure
    1 Jan 2016 - 31 Dec 2016
    People funded by this grant:
    • Sharman J,
    • Jose M,
    • Roberts-Thomson P
    Project Total: $24,140; Clinic blood pressure is usually measured by doctors but can result in falsely elevated or highly variable readings, which is a major problem for correct diagnosis and clinical care. This study will test a new, quick and automated method to measure blood pressure that is expected to improve clinical care. Funded by: Royal Hobart Hospital Research Foundation - Grant-Establishment ($24,140); University of Tasmania.
  • GRANT
    Linking exercise blood pressure to clinical outcomes: the EXERcise stress Test collaboratION (EXERTION) Tasmanian pilot study.
    1 Jan 2016 - 30 Jun 2017
    People funded by this grant:
    • Schultz M,
    • Sharman J,
    • Venn A,
    • Marwick T,
    • Thomson P
    Project Total: $10,000; The EXERcise stress Test collaboratION (EXERTION) aims to link clinical exercise testing results to cardiovascular disease outcomes, to provide the first-ever evidence-based thresholds for abnormal exercise blood pressure. Results will inform clinical guidelines, providing supervising clinicians with signposts of cardiovascular risk upon which to optimise patient management and follow-up care. Funded by: Royal Hobart Hospital Research Foundation - Grant-Starter ($10,000); University of Tasmania.
  • GRANT
    The EXERcise stress Test collaboratION - Pilot study
    1 Jan 2016 - 31 Dec 2017
    People funded by this grant:
    • Schultz M,
    • Sharman J,
    • Marwick T,
    • Venn A
    Project Total: $55,519; Data-linkage study investigating CV outcomes in relation to exercise stress testing, derivation of exercise BP thresholds. Funded by: Heart Foundation - Grant-Vanguard ($55,519); University of Tasmania.